Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30948273

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2019 May
First author
Moore KN

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 May;20(5):603-605. doi: 10.1016/S1470-2045(19)30087-7.
    note
    Source null
    related pmid
    30948274
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2019 May;20(5):e242. doi: 10.1016/S1470-2045(19)30242-6.
    note
    Source null
    related pmid
    31044718
    relationship
    Erratum in

Authors and identifiers

  1. name
    Moore KN
    type
    Author
  2. name
    Secord AA
    type
    Author
  3. name
    Geller MA
    type
    Author
  4. name
    Miller DS
    type
    Author
  5. name
    Cloven N
    type
    Author
  6. name
    Fleming GF
    type
    Author
  7. name
    Wahner Hendrickson AE
    type
    Author
  8. name
    Azodi M
    type
    Author
  9. name
    DiSilvestro P
    type
    Author
  10. name
    Oza AM
    type
    Author
  11. name
    Cristea M
    type
    Author
  12. name
    Berek JS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moore KN
    type
    Author
  2. name
    Secord AA
    type
    Author
  3. name
    Geller MA
    type
    Author
  4. name
    Miller DS
    type
    Author
  5. name
    Cloven N
    type
    Author
  6. name
    Fleming GF
    type
    Author
  7. name
    Wahner Hendrickson AE
    type
    Author
  8. name
    Azodi M
    type
    Author
  9. name
    DiSilvestro P
    type
    Author
  10. name
    Oza AM
    type
    Author
  11. name
    Cristea M
    type
    Author
  12. name
    Berek JS
    type
    Author
bibliography ids
  1. nci-bib-076cb755099fbeb36b7bfa96
book metadata
content sha256
377c4cb4095f8e5b310782c568cf74bb3058ed131e430490ce46ba9ef508045c
document type
citation
dois
  1. 10.1016/S1470-2045(19)30029-4
electronic publication date
display
2019 Apr 1
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30948273
immutable id
pubmed:30948273@377c4cb4095f8e5b310782c568cf74bb3058ed131e430490ce46ba9ef508045c
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
636-648
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 May;20(5):603-605. doi: 10.1016/S1470-2045(19)30087-7.
    note
    Source null
    related pmid
    30948274
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2019 May;20(5):e242. doi: 10.1016/S1470-2045(19)30242-6.
    note
    Source null
    related pmid
    31044718
    relationship
    Erratum in
outcomes validated
false
pmid
30948273
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
751c8af12d819981ea570474fd9ec34fef0bef63d654a303348fb5916e70d3f2
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 May
precision
month
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30948273/
title
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Preserved source evidence · Not medical advice